Research Topics
| Benjamin P LinasSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Assessing the impact of federal HIV prevention spending on HIV testing and awarenessBenjamin P Linas
Massachusetts General Hospital, 50 Staniford St, Ninth Floor, Boston, MA 02114, USA
Am J Public Health 96:1038-43. 2006..The United States allocates more than $900 million annually for the prevention of HIV infection. We assessed the impact of this funding on HIV testing and knowledge...
Optimizing resource allocation in United States AIDS drug assistance programsBenjamin P Linas
Division of General Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Clin Infect Dis 43:1357-64. 2006..We hypothesized that CD4 cell count-based ADAP eligibility would improve ADAP outcomes, allowing them to serve more-diverse patient populations and to prioritize persons who are at greatest risk of HIV-related mortality...- Improving outcomes in state AIDS drug assistance programsBenjamin P Linas
Divisions of General Medicine, Massachusetts General Hospital, Boston, MA 02115, USA
J Acquir Immune Defic Syndr 51:513-21. 2009..State AIDS Drug Assistance Programs (ADAPs) provide antiretroviral medications to patients with no access to medications. Resource constraints limit the ability of many ADAPs to meet demand for services... - The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) CohortB P Linas
Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
J Viral Hepat 18:506-12. 2011..5), 1.7 (95% CI: 1.4-2.1), and 1.6 (95% CI: 1.3-1.9) respectively. Programs serving HIV/HCV co-infected patients can expect approximately 70% higher rates of utilization than expected from a similar cohort of HIV mono-infected patients... - Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DCRochelle P Walensky
Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Clin Infect Dis 51:392-400. 2010..We forecast outcomes of this approach if implemented in Washington DC... - When to start antiretroviral therapy in resource-limited settingsRochelle P Walensky
Massachusetts General Hospital, Brigham and Women s Hospital, Harvard University Medical School, Harvard School of Public Health, and Boston University School of Public Health, Boston, Massachusetts 02114, USA
Ann Intern Med 151:157-66. 2009..The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years... - Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with menBenjamin P Linas
HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, MA 02118, USA
Clin Infect Dis 55:279-90. 2012..We used a Monte Carlo computer simulation to estimate the effectiveness and cost-effectiveness of screening for acute hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected men who have sex with men... - WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothersAndrea L Ciaranello
Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America
PLoS ONE 6:e20224. 2011..The Zimbabwean national prevention of mother-to-child HIV transmission (PMTCT) program provided primarily single-dose nevirapine (sdNVP) from 2002-2009 and is currently replacing sdNVP with more effective antiretroviral (ARV) regimens... - First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello
Division of Infectious Disease, Massachusetts General Hospital, Boston, 02114, USA
AIDS 25:479-92. 2011..nevirapine-based antiretroviral therapy (ART) among women previously exposed to single-dose nevirapine to prevent mother-to-child HIV transmission. However, lopinavir/ritonavir is 12 times costlier than nevirapine...
Research Grants
- Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance ProgramsBENJAMIN LINAS; Fiscal Year: 2007..This K01 award will lead to a novel, independent trajectory of research, and will inform HIV and HCV care and policy in the United States. ..